IP Library Granted Patent US 8,119,610
Granted Patent B2
US 8,119,610 · App. 10/448,612 · Granted Feb 21, 2012

Method for efficient RNA interference in mammalian cells

Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,119,610
App. No.
10/448,612
Granted
Feb 21, 2012
Kind
B2
Abstract

The present invention relates to methods of making RNAi libraries using E. coli RNAse III for inhibition of mammalian gene expression.

Claims (14)

1. A method of inhibiting expression of a mammalian gene, the method comprising the steps of:

(i) providing double stranded RNA having a sequence at least 95% identical to a sequence of mRNA transcribed from the mammalian gene over a comparison window of 200 continuous residues;

(ii) digesting the double stranded RNA with E. coli RNAse III in vitro to form a plurality of siRNAs capable of interacting with multiple sites of the mRNA, wherein the siRNAs are 20-25 nucleotides in length; and

(iii) transfecting mammalian cells with the plurality of siRNAs, thereby specifically inhibiting expression of the mammalian gene by at least 50%.

2. The method of claim 1 , wherein the siRNAs are 21-23 nucleotides in length.

3. The method of claim 1 , wherein the double stranded RNA is synthetic.

4. The method of claim 1 , wherein the double stranded RNA comprises single stranded RNA isolated from a naturally occurring RNA population.

5. The method of claim 1 , wherein the double stranded RNA comprises single stranded RNA corresponding to a naturally occurring RNA population.

6. The method of claim 1 , wherein the double stranded RNA is provided by synthesizing an RNA and its complement, and hybridizing the RNA and its complement to form double stranded RNA.

7. The method of claim 1 , wherein the siRNA is from mammalian RNA.

8. The method of claim 1 , wherein the siRNAs are synthetic and have sequences identical to the mammalian gene.

9. The method of claim 1 , wherein the at least 95% is 100%.

10. The method of claim 1 , wherein with E. coli RNAse III is a GST- E. coli RNAse III fusion protein.

11. The method of claim 1 , wherein the expression of the mammalian gene is inhibited by at least 90%.

Assignments (2)
CONFIRMATORY LICENSE Recorded May 17, 2012
From: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028223/0974 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2003
From: YANG, DUN; BISHOP, J. MICHAEL
To: REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE
Reel/Frame 014019/0600 →
Continuity (2)
Provisional Application 60385011 · May 31, 2002
Related Publication 20040014113A1 · Jan 22, 2004